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Purpose: Matrix metalloproteases (MMPs) are tissue-remodeling enzymes 
that function during the remodeling process, such as in immune-inflammatory 
diseases. Metalloprotease-2 (MMP-2) and metalloprotease-9 (MMP-9) are 
gelatinases that degrade several types of extracellular matrix collagen. It is 
hypothesized that in temporomandibular joint (TMJ) dysfunction, MMP-2 and 
MMP-9 expression levels may be elevated. Therefore, the objective of this 
study is to determine the association of MMP-2 and MMP-9 expression with 
temporomandibular joint dysfunction using an immunohistochemical approach 
to evaluate the joint disk. 
Material and Methods: A total of 45 human temporomandibular joint 
samples were collected, with 36 samples in the test group (patients with 
anterior disk displacement with reduction (n = 29) and without reduction 
(n = 7)) and nine samples in the control group. The immunostaining of the 
TMJ disks was statistically compared between the groups (P < 0.05). 
Results: There was a statistically significant difference for the area of MMP-2 
immunostaining between the control group and the displacement disks with 
reduction group (ADDwR) (P = 0.048) and between the groups with disk 
displacement and without reduction (ADDwoR) (P = 0.029). The expression of 
MMP-2 was significantly elevated in the ADDwoR group. 
Conclusion: No statistically significant difference was found between the 
variable area of MMP-9 expression in the disk with and without disk 
displacement, as determined by immunohistochemical analysis. However, 
there was an elevation of MMP-2 expression in the disks of patients with 
displacement and without reduction (more severe alteration). 
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The temporomandibular joint (TMJ) is a bilateral joint that 
adapts and remodels according to functional demands. The fibrous 
cartilaginous disk in the TMJ consists of regularly arranged collagen 
fibers and fibroblast-like cells. It plays an important role in distributing 
the pressure loads of articular surfaces of the condyle and glenoid 
fossa during joint movements.1 When the disk is overloaded and 
exceeds its remodeling capability, it may suffer structural changes, 
such as the fragmentation of compact collagen fibers or an alteration 
of synovial cells, which cover the disk and are responsible for its 
lubrication and can lead to TMJ disorders.2 The pathogenesis of TMJ 
dysfunction is multifactorial, but the early identification of the major 
contributing factor is critical for improved treatment outcomes. Of the 
TMJ dysfunctions that may lead to disk degeneration, anterior disc 
displacement is generally observed in TMJ patients3 and often precedes 
osseous remodeling, disk perforation, and osteoarthritic changes.4 
The inflammatory process is a coordinated response against 
trauma and infection. However, when the initiating inflammatory agent 
is not removed, this physiological response may lead to pathological 
conditions. Matrix metalloproteinases (MMPs), a family of 20 
proteolytic enzymes that degrade all types of collagen, proteoglycans, 
and other components of extracellular matrix are among the enzymes 
found in the physiological and inflammatory tissue environments.5 
Their activity is essential for remodeling and adapting cartilage and 
other tissues.6 The tissue inhibitors of metalloproteinases (TIMPs) work 
together with the MMPs during physiological alterations,7 but under 
inflammatory conditions, the excess activity and overexpression of 
MMPs results in tissue destruction. The MMPs are divided into the 
following subgroups: collagenases (MMP-1, MMP-8, and MMP-13) that 
degrade fibrillar collagen types I, II, and III; stromelysins (MMP-3 and 
MMP-11) that degrade proteoglycans and non-helical regions of 
collagens; and gelatinases (MMP-2 and MMP-9), which degrade the 
specific collagen types I, IV, V, and XI.8 
MMP-2 and MMP-9 are produced primarily by inflammatory cells, 
and their expression is regulated at the transcriptional level by 
inflammatory mediators, such as interleukin-1.9 MMP-2 and MMP-9 are 
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synthesized as latent proenzymes, which are cleaved and activated 
outside the cells. MMP-2 and MMP-9 are increased in the serum and 
synovial fluids of arthritic patients and are considered markers of 
arthritis and are also associated with cartilage degradation in animal 
experiments.10 MMP-2 was detected in early-stage osteoarthritis 
patients, whereas MMP-9 was highly expressed in patients with 
anterior disk displacement without reduction and advanced 
osteoarthritis.11 However, the sample was collected from synovial fluid, 
and the state of disk degradation was unknown during at that time. To 
better understand the progressive stage of the disease, it is important 
to acquire a detailed clinical evaluation and knowledge of the TMJ 
degenerating mechanisms.12 
Although the involvement of several MMPs in TMJ dysfunction is 
known, little has been reported regarding which MMP enzymes are 
involved in the TMJ disk disarrangements, and the elucidation of this 
relationship may contribute to improved diagnosis and treatment of 
TMJ patients. The majority of studies have been performed with 
synovial fluid,13 animal models,13,14 or cadavers.15 However, MMP-2 
and MMP-9 expressions have not been studied in the degenerated 
disks of human TMJ patients. Therefore, the objective of this study is 
to determine the association of MMP-2 and MMP-9 expressions in the 
disks of patients with temporomandibular joint dysfunction using an 
immunohistochemical approach to evaluate the joint disk. 
Materials and methods 
Sample selection 
The sample set comprised 45 disk specimens (Table 1) from 33 
patients, male and female, with a mean age of 32.36 years (17–57). A 
total of 36 TMJ displaced disk specimens were collected from patients 
treated between 2002 and 2009 at the Evangelic University Hospital of 
Curitiba, Brazil. Nine virtually unaffected human TMJ disks were 
evaluated with the pathological material. The study was approved by 
the Ethical Committee on Research at Pontifical Catholic University of 
Paraná, Brazil, according to Resolution 196/96 of the National Health 
Council and approved under registration number 104. 
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Table 1. Baseline clinical characteristics of the study group with and without 
TMJ dysfunction 
Patient 
(n = 33) 






1. ADDwoR, anterior disk displacement without reduction; ADDwR, anterior disk 
displacement with reduction; C FX, condylar fracture; CH, condylar 
hyperplasia. 
1 Caucasian Female 35 DDwoR X X 
2 Caucasian Female 24 DDwoR   X 
3 Caucasian Female 23 DDwoR X X 
4 Caucasian Female 45 DDwoR X   
5 Caucasian Female 32 DDwoR X   
6 Caucasian Female 30 ADDwR   X 
7 Afro-
American 
Female 20 ADDwR   X 
8 Afro-
American 
Female 57 ADDwR   X 
9 Caucasian Female 33 ADDwR X   
10 Caucasian Female 25 ADDwR X X 
11 Caucasian Female 22 ADDwR X X 
12 Caucasian Female 42 ADDwR X   
13 Caucasian Female 56 ADDwR X   
14 Caucasian Female 26 ADDwR X X 
15 Caucasian Female 38 ADDwR X X 
16 Caucasian Female 37 ADDwR X X 
17 Caucasian Female 36 ADDwR X X 
18 Caucasian Female 34 ADDwR   X 
19 Caucasian Female 46 ADDwR X X 
20 Caucasian Female 26 ADDwR X X 
21 Caucasian Female 30 ADDwR X X 
22 Caucasian Female 36 ADDwR X   
23 Caucasian Female 44 ADDwR X   
24 Caucasian Female 26 ADDwR X X 
25 Caucasian Female 17 CH   X 
26 Caucasian Female 43 C FX   X 
27 Caucasian Female 40 CH   X 
28 Caucasian Female 18 CH   X 
29 Caucasian Male 26 C FX X   
30 Caucasian Female 30 CH   X 
31 Afro-
American 
Male 26 CH X   
32 Caucasian Male 27 C FX X   
33 Caucasian Male 18 C FX   X 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Journal of Oral Pathology & Medicine, Vol 44, No. 1 (January 2015): pg. 75-79. DOI. This article is © Wiley and permission 
has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article 
to be further copied/distributed or hosted elsewhere without the express permission from Wiley. 
6 
 
The subjects did not have any of the following: use of 
orthodontic appliances; chronic usage of anti-inflammatory drugs; 
history of diabetes, hepatitis, or HIV infection; immunosuppressive 
chemotherapy; history of any disease known to severely compromise 
immune function; current pregnancy or lactation; dentofacial 
deformity; major jaw trauma; previous TMJ surgery; and previous 
steroid injection in the TMJ. The subjects completed personal medical 
history questionnaires and, within a protocol approved by an 
Institutional Review Board, signed a consent form after being advised 
of the nature of the study. All patients were asked to complete a pain 
questionnaire, and an experienced oral and maxillofacial surgeon 
performed a clinical examination. The clinical examination consisted of 
palpating the TMJ region, noting the occurrence of painful 
opening/closing of the mouth, and listening for crepitation. The 
patients considered affected were treated surgically when they 
presented painful clinical signs of disk displacement after unsuccessful 
non-surgical treatment for at least 6 months. Patients presenting with 
pain related to muscular spasms were not included in this study. For 
the complementary exams, all patients received a panorex. These 
patients were from the Brazilian public health system; therefore, very 
few patients had the financial means to afford other exams, such as 
computerized tomography (CT) scan or a TMJ magnetic resonance 
imaging. 
Accordingly, the diagnoses were primarily clinical. The subjects 
were included in clinical categories, according to the presence or 
absence of disk displacement.  
1. Test group: composed of 36 samples, and all patients were 
diagnosed with one of the two following TMJ dysfunctions: (i) 
disk displacement with reduction (ADDwR, n = 29) or (ii) disk 
displacement without reduction (ADDwoR, n = 7). ADDwoR is 
considered the more severe condition. 
2. Control group (n = 9): composed of patients with no signs or 
symptoms of TMJ dysfunction, such as pain or mouth opening 
limitation. Of the control patients, four individuals presented 
condyle fractures (CFx) confirmed by radiographs and CT scans 
and needed surgery for fracture reduction, and five subjects 
displayed active condyle hyperplasia (CH). Therefore, a wedge 
of the posterior region of the disks of all subjects was removed 
to physiologically adapt the disk on the condyle head. 
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MMP-2 and MMP-9 immunohistochemical analysis 
The TMJ disk sections were deparaffinized with xylol 
(2 × 10 min) and rehydrated with absolute ethyl alcohol (3 × 1 min) 
and 80% ethyl alcohol (1 × 1 min). 
Endogenous peroxidase activity was quenched by treatment 
with H2O2 (5% in methanol) for 10 min. Target Retrieval Solution™ 
(Dako, DK-2600 Glostrup, Denmark) was used prior to slide staining 
for heat-inducing epitope retrieval for formalin-fixed, paraffin-
embedded material, according to the manufacturer's instructions. 
The sections were incubated with monoclonal MMP-2 and MMP-9 
antibodies (Novocastra, New Castle, UK) diluted 1:50 in phosphate-
buffered saline (PBS) and 0.1% bovine serum albumin (BSA). These 
monoclonal antibodies only stain a cellular fraction of MMP-2 and MMP-
9. 
For negative controls, the primary antibody was not added, and 
PBS was used instead. The secondary antibody Advance™ (Dako, DK-
2600 Glostrup, Denmark) was applied for 30 min, according to the 
manufacturer's instructions. 
The immunoreactions were visualized by incubating the sections 
with 1 drop 3,3′ diaminobenzidine (DAB) chromogen (OriGene, 
Rockville, MD, USA) in 1 ml distilled water. The sections were lightly 
counterstained with Harris hematoxylin for 5 min and finally mounted. 
The immunostaining was considered specific to MMP-2 and MMP-9 
because immunoreactivity was not observed in the negative controls. 
The positive areas were marked using the color morphometry 
method, which consisted of an analysis of the anti-MMP-2 and MMP-9 
reaction area with the TMJ disk tissue. For this purpose, images of 
consecutive fields were captured with a 40× objective lens coupled to 
a BX50 Olympus microscope with a Sony camera (Model DXC-107A), 
and image analysis was performed with Image Pro Plus software 
(Media Cybernetics Inc., Silver Spring, MD, USA). This software allows 
an observer to select and paint the positive areas to obtain an image 
model and make a mask for staining the other slides. A single blinded 
observer performed this procedure. Moreover, the software 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Journal of Oral Pathology & Medicine, Vol 44, No. 1 (January 2015): pg. 75-79. DOI. This article is © Wiley and permission 
has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article 
to be further copied/distributed or hosted elsewhere without the express permission from Wiley. 
8 
 
automatically calculates the area of the positive reaction. The data 
were entered into a spreadsheet, and Microsoft Excel (Redmond, WA, 
USA) was used for the statistical analysis. The variable area was 
measured in square micrometers (μm2) and was obtained with the 
mean of all positive areas. 
Statistical analysis 
SPSS version 14.0 (SPSS Institute, Inc., Chicago, IL, USA) was 
used for the statistical analyses. To analyze the area and density, the 
average of the results from all available samples of each patient was 
considered. Descriptive statistical values are presented as the mean 
and standard deviation, median, minimum, and maximum. 
Comparisons of the three groups were performed with one-way 
analysis of variance (ANOVA) and LSD (least significant difference) for 
multiple comparisons. To achieve the symmetric condition, the data 
were previously submitted to a logarithmic transformation. A value of 
P < 0.05 indicates statistical significance. 
Results 
MMP-2 expression analysis 
A significant difference was found between the groups with and 
without TMJ dysfunction (P = 0.030) for the MMP-2 area of expression 
(Table 2). There was increased MMP-2 immunostaining in the ADDwR 
group compared with the control group (P = 0.048). There was an 
increased level of expression in the ADDwoR group compared with the 
ADDwR group (P = 0.029; Table 2). 
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Table 2. Analysis of MMP-2 expression area between the groups 
Variable Group n  Media Median Minimum Maximum Standard 
deviation 
P-valuea 
1. CG, control group; ADDwoR, disk displacement without reduction; ADDwR, 
disk displacement with reduction. 
2. a One-way ANOVA, P < 0.05 Area: CG × ADDwR: P = 0.048; CG × ADDwoR: 
P = 0.725; ADDwR × ADDwoR: P = 0.029. 
Area 
(μm2) 
CG 9 23.11 16.61 14.15 39.14 9.55 0.030 
ADDwR 29 16.16 15.18 7.90 31.28 5.77 
ADDwoR 7 28.98 26.15 6.68 58.05 19.09 
MMP-9 expression analysis 
Comparison of the control and affected groups with or without 
reduction showed no significant difference for the MMP-9 area of 
immunostaining (P = 0.476; Table 3). 
Table 3. Analysis of MMP-9 expression area between the groups 
Variable Group n  Media Median Minimum Maximum Standard 
deviation 
P-valuea 
1. CG, control group; ADDwoR, disk displacement without reduction; ADDwR, 
disk displacement with reduction. 
2. a One-way ANOVA, P < 0.05. 
Area 
(μm2) 
CG 9 21.2 15.8 6.8 53.9 15.7 0.476 
ADDwR 31 18.1 16.1 2.1 102.6 17.6 
ADDwoR 7 29.5 21.8 6.8 101.3 32.8 
Discussion 
The articular disk of human in the TMJ adapts and remodels 
when subjected to loading. When the loading pressure reaches a high 
level, the inflammatory process is initiated and may entail the 
degradation and replacement of the natural matrix by abnormal 
tissue.16 The upregulation of some MMPs has been observed in 
pathological conditions in the TMJ synovial fluid, resulting in tissue 
destruction, and MMPs are considered the primary enzymes involved in 
matrix turnover.15,17-20 MMP gene polymorphisms have been associated 
with temporomandibular joint degeneration,21 whereas MMP-9 gene 
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promoter polymorphisms were associated with degenerative diseases, 
such as arthritis and atherosclerosis.22 
MMP-2 and MMP-9 expressions are regulated by several growth 
factors, such as platelet derived growth factor, tumor necrosis factor α, 
and interleukin-1. The latent presence of MMP-2 has been identified in 
healthy joints and is produced by fibroblasts, whereas MMP-9 is 
produced in large quantities by inflammatory cells, particularly in 
patients with osteoarthritis.11 Both MMP-2 and MMP-9 are hypothesized 
to play multiple roles in TMJ pathogenesis because MMP-2 activates 
MMP-13 and because increased expression of MMP-2, concomitant with 
MMP-9, was observed in pathological conditions.2,21 However, studies 
of these two enzymes have been performed in either animal models, 
cadavers, or the synovial fluid of human pathological TMJ. To the best 
of our knowledge, this is the first study to investigate the presence of 
MMP-2 and MMP-9 in human temporomandibular disks. 
Our results showed statistically significant differences between 
CG and ADDwR and between ADDwoR and ADDwR. Notably, the 
expression of MMP-2 was also significantly increased in the disk 
displacement without reduction group compared with the disk 
displacement with reduction group and the control group. No 
difference was observed between the control group and ADDwoR. 
Although the lack of difference may be due to the small sample size 
and high variability in the expression of MMP-2 in these groups, it may 
also indicate the association of the increased expression of MMP-2 with 
a more severe TMJ disorder. The MMP-9 analysis showed no 
statistically significant difference between the groups in relation to the 
area of expression. The results of this study differ from the results of 
Yoshida et al.11 who found higher levels of MMP-9 in the synovial fluid 
in advanced TMJ disease. Moreover, the lack of difference between the 
groups may be related to the small number of individuals and the high 
variability of MMP-9 expression within each group. Another possible 
explanation is that there may be a difference between MMP-9 
expression in the synovial fluid and the disks during TMJ dysfunction. 
It is notable that although the sample size is reduced, only 
approximately 5% of people worldwide present a functional or 
pathological TMJ condition amenable to surgery,23 and for ethical 
reasons, it is not possible to retrieve healthy retrodiscal tissue from 
normal patients to serve as controls. Moreover, the absence of MMP 
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expression between the groups may be because the control group 
consisted of disks from patients with condyle fracture. However, for 
the controls presenting with mandibular condyle fracture, the surgical 
procedure occurred up to 24 h after the trauma, which diminishes the 
action of MMP degradation in the area. For the controls with 
hyperplasia, because hyperplasia is restricted to the condyle, this 
condition does not appear to affect the articular disk. 
Although the sample size is small, to the best of our knowledge, 
this study has the largest sample of disks from living people, as 
opposed to disks from cadavers or from animals. Moreover, for human 
cadavers, no previous clinical records were available, which made it 
impossible to determine whether the subjects presented with any 
inflammatory degenerative alterations. 
With an increasing number of patients presenting with TMJ 
dysfunction, the identification of the disease stage is a priority for 
directing proper treatment. In this study, increased expression of 
MMP-2 was observed in patients with disk displacement without 
reduction by immunohistochemistry analysis. No statistically significant 
difference was found in the area of expression of MMP-9, possibly 
because of the high interindividual variation in its expression, which 
therefore requires a larger number of individuals to determine whether 
the level of this protease is increased in the disks of individuals with 
TMJ dysfunction. 
Future analyses of other MMPs combined with the results of this 
study may contribute to a better understanding of the role of MMPs on 
tissue remodeling and destruction. These studies may also improve the 
understanding of TMJ dysfunction and lead to improved patient 
treatments. 
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